Pharma

pharmaand GmbH (pharma & ), a privately owned global company, aspires to breathe new life into proven medicines. The Company is dedicated to preserving the availability and fostering the further development of essential medicines worldwide to leave no patient behind. Since 2017, pharma & has aggregated 10+ medicines, expanding its portfolio across a wide range of therapy areas, with an increasing focus on hematology and oncology treatments. pharma & ’s unique approach enables it to provide its portfolio of medicines to eligible patients worldwide by spanning the continuum of research and development, in-house product and API manufacturing, distribution via its global partner network, healthcare provider engagement, patient safety services, and patient access services through U.S. Market Access.